Sphaera receives Notice of Allowance from United States Patent and Trademark Office for Novel Triazine Compounds.
Sphaera Pharma has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its Patent application titled ‘Novel Triazine Compounds’.
Field of Invention: The present invention relates to novel triazine compounds that may be useful as kinase inhibitors. More particularly, the present invention relates to substituted triazine derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of PI3K/mTOR pathway related disorders.
+91 124 4187500
About Sphaera Pharma:
Sphaera Pharma is an integrated drug discovery and development organization led by pharma and biotech professionals. With its global presence in India, Singapore and the US, Sphaera aims to bridge innovation, resources and expertise in a collaborative model to develop novel therapies.